Loading...
Loading...
Contributors:
Dataset URI:
10.5281/zenodo.23696862Relevance. Chronic periodontitis affects about half of adults worldwide [1], and fatty liver disease has an estimated global prevalence of about 24% [2]. Both are chronic inflammatory conditions that frequently coexist in the setting of metabolic syndrome. In 2023 a multisociety consensus replaced the term NAFLD with metabolic dysfunction-associated steatotic liver disease (MASLD), which requires hepatic steatosis plus at least one of five cardiometabolic risk factors [3]. Because periodontitis is a modifiable factor and its treatment may improve liver parameters [4], a clinical and immunological rationale for a combined approach is needed.
Keyword(s):
MeSH Term(s):
Grants and Funding:
No Grants or Funding Data Available
Associated Publication(s):
No Associated Publication Data Available
Supplementary Data:
No Supplementary Data Available
Related Dataset(s):
No Related Dataset Data Available
The National Library of Medicine (NLM) provides information about biomedical datasets. Inclusion on an NLM Web page does not imply endorsement of, or agreement with, the contents by NLM or the National Institutes of Health. Learn more: NLM Web Policies (nih.gov)